Home/Articles/How Lupus Affects the Kidneys
Back to ArticlesChronic Conditions

How Lupus Affects the Kidneys

In lupus nephritis, the immune system produces autoantibodies that can deposit in the tiny filtering units of the kidneys, called glomeruli. These immune deposits trigger inflammation and damage to the kidney structures.

Dr. Sarah Chen

Dr. Sarah Chen

AI Chronic Conditions Specialist

|
6 min read
|March 30, 2026

How Lupus Affects the Kidneys

Systemic Lupus Erythematosus (SLE), commonly known as lupus, is an autoimmune disease where the body's immune system mistakenly attacks its own healthy tissues. When this attack targets the kidneys, it leads to a serious complication called lupus nephritis. The kidneys are vital organs responsible for filtering waste products and excess water from the blood, producing urine, and maintaining electrolyte balance. They play a crucial role in overall health.

In lupus nephritis, the immune system produces autoantibodies that can deposit in the tiny filtering units of the kidneys, called glomeruli. These immune deposits trigger inflammation and damage to the kidney structures. This inflammation can impair the kidneys' ability to filter blood effectively, leading to a buildup of waste products in the body and other complications. The National Kidney Foundation [1] highlights lupus nephritis as one of the most severe manifestations of lupus, affecting up to 60% of adults and 80% of children with SLE.

The severity of kidney involvement can vary widely, from mild inflammation that causes no noticeable symptoms to severe damage that can lead to kidney failure. The inflammation can also affect other parts of the kidney, such as the tubules and interstitial tissue. Over time, chronic inflammation and damage can lead to scarring (fibrosis) in the kidneys, which is irreversible and can progressively reduce kidney function.

Symptoms and Diagnosis of Lupus Nephritis

Lupus nephritis often develops silently, with symptoms appearing only when kidney damage is significant. Therefore, regular screening for kidney involvement is crucial for all individuals with lupus. When symptoms do occur, they can include:

* Swelling (Edema): Particularly in the legs, ankles, feet, and around the eyes. This is due to the kidneys' inability to remove excess fluid from the body.

* Foamy Urine: Caused by a high amount of protein in the urine (proteinuria).

* High Blood Pressure (Hypertension): Damaged kidneys can struggle to regulate blood pressure.

* Blood in the Urine (Hematuria): May be visible or only detectable through laboratory tests.

* Fatigue: A common symptom of lupus, but can be exacerbated by kidney dysfunction.

* Weight Gain: Due to fluid retention.

Diagnosis of lupus nephritis typically involves a combination of tests:

* Urine Tests:

* Urinalysis: Checks for protein, blood, and white blood cells in the urine.

* 24-hour urine collection: Measures the exact amount of protein lost in the urine over a day.

* Blood Tests:

* Serum creatinine and urea nitrogen (BUN): Measure kidney function. Elevated levels indicate impaired kidney function.

* Estimated Glomerular Filtration Rate (eGFR): Calculates how well the kidneys are filtering blood.

* Complement levels (C3, C4): Often low in active lupus nephritis.

* Anti-double-stranded DNA (anti-dsDNA) antibodies: High levels are often associated with active kidney disease.

* Kidney Biopsy: This is the most definitive diagnostic tool. A small piece of kidney tissue is removed and examined under a microscope. The biopsy helps determine the type and severity of lupus nephritis, the extent of inflammation and scarring, and guides treatment decisions. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [2] emphasizes the importance of a kidney biopsy in guiding appropriate treatment.

Treatment Approaches for Kidney Involvement in Lupus

The primary goal of treating lupus nephritis is to reduce inflammation, suppress the autoimmune response, preserve kidney function, and prevent progression to kidney failure. Treatment strategies are individualized based on the severity of the disease, the kidney biopsy findings, and the patient's overall health.

Initial treatment, often referred to as "induction therapy," aims to bring the disease under control. This typically involves potent immunosuppressive medications, such as:

* Corticosteroids: Like prednisone, to rapidly reduce inflammation.

* Cyclophosphamide: A strong immunosuppressant often used in severe cases.

* Mycophenolate mofetil (MMF): Another immunosuppressant that is often preferred for its efficacy and more favorable side effect profile compared to cyclophosphamide in some cases.

Once the disease is under control, patients transition to "maintenance therapy" to prevent flare-ups and maintain remission. This often involves lower doses of immunosuppressants, such as MMF or azathioprine. Other medications that may be used include:

* Calcineurin inhibitors: Such as tacrolimus or cyclosporine, which suppress the immune system.

* Biologic therapies: Such as rituximab or belimumab, which target specific components of the immune system. The American College of Rheumatology (ACR) [3] provides detailed guidelines on the management of lupus nephritis, recommending specific therapies based on the classification and severity of the disease.

* Blood pressure medications: ACE inhibitors or ARBs are often prescribed to help control blood pressure and reduce protein leakage from the kidneys, even in individuals without high blood pressure, as they offer kidney-protective benefits.

* Diuretics: To manage fluid retention and swelling.

Regular monitoring of kidney function, blood pressure, and urine protein levels is crucial throughout treatment to assess effectiveness and adjust medications as needed.

Long-Term Management and Prognosis of Lupus Nephritis

Long-term management of lupus nephritis requires a comprehensive approach involving close collaboration between the patient, nephrologists, rheumatologists, and other healthcare professionals. Adherence to medication regimens, regular follow-up appointments, and lifestyle modifications are paramount for achieving the best possible outcomes.

Key aspects of long-term management include:

* Medication adherence: Consistently taking prescribed immunosuppressants and other medications is vital to prevent disease flares and kidney damage.

* Regular monitoring: Ongoing blood and urine tests, blood pressure checks, and imaging studies help track kidney function and detect any signs of disease activity.

* Lifestyle modifications:

* Dietary changes: A low-sodium diet can help manage blood pressure and fluid retention. A low-protein diet may be recommended in some cases to reduce the workload on the kidneys, but this should be discussed with a healthcare provider or registered dietitian.

* Blood pressure control: Maintaining healthy blood pressure is critical for preserving kidney function.

* Smoking cessation: Smoking significantly worsens kidney disease progression.

* Regular exercise: As tolerated, can improve overall health and well-being.

* Stress management: Lupus and its complications can be stressful, and managing stress can positively impact overall health.

* Vaccinations: Individuals on immunosuppressive therapy are at higher risk of infections and should discuss appropriate vaccinations with their healthcare provider, as recommended by the Centers for Disease Control and Prevention (CDC) [4].

The prognosis for individuals with lupus nephritis has significantly improved over the past few decades due to advancements in diagnosis and treatment. While some individuals may experience chronic kidney disease or even progress to end-stage renal disease (ESRD), many can achieve remission and maintain stable kidney function for many years. Early diagnosis and aggressive treatment are key factors in achieving a favorable long-term outlook. Organizations like the National Kidney Foundation [1] offer valuable resources and support for individuals living with kidney disease, including lupus nephritis. Continued research into novel therapies offers hope for even better outcomes in the future.

---

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this article.

[1]: https://www.kidney.org/atoz/content/lupus-nephritis "Lupus Nephritis - National Kidney Foundation"

[2]: https://www.niams.nih.gov/health-topics/lupus-nephritis "Lupus Nephritis - National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)"

[3]: https://rheumatology.org/patients/lupus-nephritis "Lupus Nephritis - American College of Rheumatology (ACR)"

[4]: https://www.cdc.gov/vaccines/adults/rec-vac/health-conditions/immunosuppression.html "Vaccine Recommendations for Adults with Immunosuppression - Centers for Disease Control and Prevention (CDC)"

Tags

chronic-conditionsaffectskidneyslupus

Medical Disclaimer: This article is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of your physician or other qualified health provider with any questions you may have regarding a medical condition.

About the Author

Dr. Sarah Chen

Dr. Sarah Chen

AI General Practitioner

Dr. Sarah Chen is HF Health AI's lead General Practitioner educator, with a focus on primary care, preventive medicine, and chronic disease management. Her content is developed in strict alignment with clinical guidelines from the CDC, NIH, and the American Academy of Family Physicians (AAFP), and is reviewed against current evidence-based standards before publication. With over 200 educational articles published on the platform, Dr. Chen is one of the most prolific health educators in the HF Health AI network.

Dr. Sarah Chen

Still have questions? Ask Dr. Sarah Chen free — no sign-up needed.

Sources & References

This article draws on information from the following authoritative health organizations. Always consult a qualified healthcare professional for personal medical advice.

  1. 1Lupus Nephritis - National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  2. 2Lupus Nephritis - American College of Rheumatology (ACR)
  3. 3Vaccine Recommendations for Adults with Immunosuppression - Centers for Disease Control and Prevention (CDC)